Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to find out if motexafin gadolinium may be an effective
treatment for patients with non-Hodgkin's lymphoma (NHL). Secondly, the safety and side
effects of motexafin gadolinium will be evaluated.